We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong income characteristics for investors to consider today, December 21st:
China Petroleum & Chemical Corporation : This energy and chemical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
China Petroleum & Chemical Corporation Price and Consensus
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 7.4%, compared with the industry average of 5.2%. Its five-year average dividend yield is 5.9%.
China Petroleum & Chemical Corporation Dividend Yield (TTM)
DCP Midstream, LP : This owner, operator, acquirer, and developer of a portfolio of midstream energy assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.
Hess Midstream LP (HESM - Free Report) : This owner, operator, developer, and acquirer of midstream assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Sprague Resources LP : This company that engages in the purchase, storage, distribution, and sale of refined petroleum products and natural gas has witnessed the Zacks Consensus Estimate for its current year earnings increasing 54% over the last 60 days.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Top Ranked Income Stocks to Buy for December 21st
Here are four stocks with buy rank and strong income characteristics for investors to consider today, December 21st:
China Petroleum & Chemical Corporation : This energy and chemical company has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
China Petroleum & Chemical Corporation Price and Consensus
China Petroleum & Chemical Corporation price-consensus-chart | China Petroleum & Chemical Corporation Quote
This Zacks Rank #1 (Strong Buy) company has a dividend yield of 7.4%, compared with the industry average of 5.2%. Its five-year average dividend yield is 5.9%.
China Petroleum & Chemical Corporation Dividend Yield (TTM)
China Petroleum & Chemical Corporation dividend-yield-ttm | China Petroleum & Chemical Corporation Quote
DCP Midstream, LP : This owner, operator, acquirer, and developer of a portfolio of midstream energy assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing 18.7% over the last 60 days.
DCP Midstream Partners, LP Price and Consensus
DCP Midstream Partners, LP price-consensus-chart | DCP Midstream Partners, LP Quote
This Zacks Rank #1 company has a dividend yield of 8.2%, compared with the industry average of 7.1%. Its five-year average dividend yield is 11.7%.
DCP Midstream Partners, LP Dividend Yield (TTM)
DCP Midstream Partners, LP dividend-yield-ttm | DCP Midstream Partners, LP Quote
Hess Midstream LP (HESM - Free Report) : This owner, operator, developer, and acquirer of midstream assets has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.
Hess Midstream Partners LP Price and Consensus
Hess Midstream Partners LP price-consensus-chart | Hess Midstream Partners LP Quote
This Zacks Rank #1 company has a dividend yield of 8.6%, compared with the industry average of 8.2%. Its five-year average dividend yield is 6.9%.
Hess Midstream Partners LP Dividend Yield (TTM)
Hess Midstream Partners LP dividend-yield-ttm | Hess Midstream Partners LP Quote
Sprague Resources LP : This company that engages in the purchase, storage, distribution, and sale of refined petroleum products and natural gas has witnessed the Zacks Consensus Estimate for its current year earnings increasing 54% over the last 60 days.
Sprague Resources LP Price and Consensus
Sprague Resources LP price-consensus-chart | Sprague Resources LP Quote
This Zacks Rank #1 company has a dividend yield of 14.1%, compared with the industry average of 8.5%. Its five-year average dividend yield is 12.2%.
Sprague Resources LP Dividend Yield (TTM)
Sprague Resources LP dividend-yield-ttm | Sprague Resources LP Quote
See the full list of top ranked stocks here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>